Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

2.89
0.0000
Post-market: 2.890.00000.00%16:05 EDT
Volume:17.81K
Turnover:51.43K
Market Cap:25.58M
PE:-6.06
High:2.93
Open:2.88
Low:2.88
Close:2.89
Loading ...
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 09, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2020

Major Issues Report

8-K - Current report
Sep 09, 2020

Major Issues Report

8-K - Current report